Lysosomal storage disorders: The cellular impact of lysosomal dysfunction

被引:510
|
作者
Platt, Frances M. [1 ]
Boland, Barry [2 ]
van der Spoel, Aarnoud C. [3 ,4 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
[2] Univ Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland
[3] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat & Biochem, Halifax, NS B3H 4R2, Canada
[4] Dalhousie Univ, Atlantic Res Ctr, Dept Mol Biol, Halifax, NS B3H 4R2, Canada
关键词
CHAPERONE-MEDIATED AUTOPHAGY; ENZYME REPLACEMENT THERAPY; CALCIUM HOMEOSTASIS; LATE ENDOSOMES; MOUSE MODEL; MITOCHONDRIAL ABERRATIONS; CHOLESTEROL ACCUMULATION; SALVAGE PATHWAY; GENE-THERAPY; DISEASE;
D O I
10.1083/jcb.201208152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lysosomal storage diseases (LSDs) are a family of disorders that result from inherited gene mutations that perturb lysosomal homeostasis. LSDs mainly stem from deficiencies in lysosomal enzymes, but also in some non-enzymatic lysosomal proteins, which lead to abnormal storage of macromolecular substrates. Valuable insights into lysosome functions have emerged from research into these diseases. In addition to primary lysosomal dysfunction, cellular pathways associated with other membrane-bound organelles are perturbed in these disorders. Through selective examples, we illustrate why the term "cellular storage disorders" may be a more appropriate description of these diseases and discuss therapies that can alleviate storage and restore normal cellular function.
引用
收藏
页码:723 / 734
页数:12
相关论文
共 50 条
  • [1] Autophagy in lysosomal storage disorders
    Lieberman, Andrew P.
    Puertollano, Rosa
    Raben, Nina
    Slaugenhaupt, Susan
    Walkley, Steven U.
    Ballabio, Andrea
    AUTOPHAGY, 2012, 8 (05) : 719 - 730
  • [2] Lysosomal disorders: From storage to cellular damage
    Ballabio, Andrea
    Gieselmann, Volkmar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04): : 684 - 696
  • [3] Mitochondria Dysfunction and Neurodegeneration in Lysosomal Storage Disorders
    Plotegher, Nicoletta
    Duchen, Michael R.
    TRENDS IN MOLECULAR MEDICINE, 2017, 23 (02) : 116 - 134
  • [4] Gene therapy for lysosomal storage disorders
    Gritti, Angela
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (09) : 1153 - 1167
  • [5] Sphingolipid lysosomal storage disorders
    Platt, Frances M.
    NATURE, 2014, 510 (7503) : 68 - 75
  • [6] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [7] Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
    Stepien, Karolina M.
    Roncaroli, Federico
    Turton, Nadia
    Hendriksz, Christian J.
    Roberts, Mark
    Heaton, Robert A.
    Hargreaves, Iain
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 22
  • [8] Lysosomal Storage Disorders
    Stulnig, T.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2011, 4 (02): : 22 - 26
  • [9] An update on gene therapy for lysosomal storage disorders
    Nagree, Murtaza S.
    Scalia, Simone
    McKillop, William M.
    Medin, Jeffrey A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (07) : 655 - 670
  • [10] Lysosomal storage disorders
    Beck, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (07) : 653 - 661